The Global Drug Discovery Technologies Market is poised to grow at a CAGR of around 12.2% over the next decade to reach approximately $160 billion by 2025.
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.
Some of the prominent trends that the market is witnessing include growing identification of combinatorial chemistry technology, regulatory initiatives fostering demand for pharmacogenomics technology, proteomics in anticancer drug discovery and human protein microarray for various protein analysis.
Based on technology the market is categorized into pharmacogenomics, high throughput screening, genomics, bioinformatics, biochips, bioanalytical Instruments, nanotechnology, metabolomics and other technologies. Depending on the end users the market is segmented by research institutes, pharmaceutical companies, biotech companies, biopharmaceutical companies and other end users.
Depending on the Applications the market is segmented by cardiovascular diseases, cancer Parkinson's disease, central nervous system disorders and other applications.
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
Key Topics Covered:
1 Market Outline
1.2 Market Trends
1.3 Regulatory Factors
1.4 Technology Analysis
1.5 Application Analysis
1.6 End User Analysis
1.7 Strategic Benchmarking
1.8 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Growing identification of combinatorial chemistry technology
3.1.2 Regulatory initiatives fostering demand for pharmacogenomics technology
3.1.3 Proteomics in anticancer drug discovery
3.1.4 Human protein microarray for various protein analysis
3.4 Industry Attractiveness
4 Drug Discovery Technologies Market, By Technology Type
4.2 High Throughput Screening
188.8.131.52 Structural Genomics
184.108.40.206 Functional Genomics
220.127.116.11 Other Genomics technologies
18.104.22.168.1.1 Clinical Medicine
22.214.171.124.1.2 New Antibiotics
126.96.36.199 Computer-Aided Drug Design
188.8.131.52 Lab on a chip
184.108.40.206 Proteomics microarrays
220.127.116.11 DNA and Protein microarrays
4.6 Bioanalytical Instruments
18.104.22.168 Chemotherapy instruments
22.214.171.124 Mass spectrometry
126.96.36.199 Microplate readers
188.8.131.52 Nuclear magnetic resonance
184.108.40.206 Nano-mass spectroscopy
220.127.116.11 Dip-pen Nanolithography
18.104.22.168 Atomic force microscopy (AFM)
22.214.171.124 Target Identification
126.96.36.199 Target Validation
188.8.131.52 Lead Optimization
184.108.40.206 Mode of Action
220.127.116.11 Preclinical Studies
18.104.22.168 Clinical Studies
22.214.171.124 Post-Approval Studies
4.9 Other Technologies
126.96.36.199 RNAi (RNA interference)
188.8.131.52.1.1 MiRNAS (MicroRNA sequencing)
184.108.40.206.1.2 SiRNA (Small interfering RNA)
220.127.116.11.1.3 Other RNAi technologies
18.104.22.168 Combinatorial chemistry
22.214.171.124.1.1 Chemical Encoding
126.96.36.199.1.2 Positional Encoding
188.8.131.52.1.3 Electronic Encoding
184.108.40.206 Synthetic Biology
220.127.116.11.1.1 Two dimensional gel electrphoresis- 2DGE
18.104.22.168.1.2 Two-hybrid systems
22.214.171.124 Cell Based Assays
126.96.36.199 Systems Biology
188.8.131.52.1.1 Computer Modelling
184.108.40.206 Quantitative polymerase chain reaction (QPCR)
220.127.116.11 Laboratory information management systems
18.104.22.168 Protein and nucleic acid isolation
5 Drug Discovery Technologies Market, By End User
5.1 Research Institutes
5.2 Pharmaceutical Companies
5.3 Biotech Companies
5.4 Biopharmaceutical Companies
5.5 Other End Users
6 Drug Discovery Technologies Market, By Application
6.1 Cardiovascular Diseases
6.3 Parkinson's disease
6.4 Central Nervous System Disorders
6.5 Other Applications
6.5.1 Other Applications Market Forecast to 2025 (US$ MN)
7 Drug Discovery Technologies Market, By Geography
8 Key Player Activities
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities
9 Leading Companies
- Affymetrix Inc.
- Tecan Group Ltd.
- Sigma-Aldrich Corp
- Shimadzu Corp
- Perkinelmer Inc.
- Thermo Fisher Scientific Inc.
- Incyte Corp
- Gyros AB
- F. Hoffmann-La Roche Ltd.
- Evotec AG
- Chembridge Corp
- Abbott Laboratories Inc.
- Celera Corp
- Caliper Life Sciences Inc.
- Bio-Rad Laboratories Inc.
- Astrazeneca Plc.
- Albany Molecular Research Inc.
- Agilent Technologies Inc.
- Charles River Laboratories International Inc.
- Life Technologies Corp
For more information about this report visit http://www.researchandmarkets.com/research/n5klng/global_drug
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-160-billion-drug-discovery-technologies-market-analysis--trends-2013-2017--industry-forecast-to-2025---research-and-markets-300413821.html
SOURCE Research and Markets